谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

ALPHA3: A Pivotal Phase 2 Study Evaluating the Safety and Efficacy of First-Line (1L) Consolidation with Cemacabtagene Ansegedleucel (Cema-Cel) in Patients with Large B-Cell Lymphoma (LBCL) and Minimal Residual Disease (MRD) after Response to Standard Therapy

Jason Westin, John Burke,Ryan Lynch,Jeremy Abramson,Don Stevens,Matthew Matasar,Lindsey Fitzgerald, Alan Zausner Skarbnik,Chaitanya Iragavarapu,James Essell,Bradley Hunter,Akil Merchant,Indumathy Varadarajan,Anand Tandra,Edward Licitra,Locke Bryan,Rushang D. Patel, Rajesh Behl, Jeff Sharmann, Houston E. Holmes,Suzanne Fanning,Habte Yimer,Mitul Gandhi,Gary Simmons,Amy Feng,Lynn Navale, Srinivas Ghatta, John B. Le Gall, Alex F. Herrera

Clinical Lymphoma Myeloma and Leukemia（2024）

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要